Anick Bérard PhD FISPE Research chair FRQS on Medications and Pregnancy Director, Réseau Québécois de recherche sur le médicament (RQRM) Professor, Research Chair on Medications, Pregnancy and Lactation Faculty of Pharmacy, University of Montrealand Director, Research Unit on Medications and Pregnancy Research Center CHU Ste-Justine

Risk of Spontaneous Abortion & Birth Defects with Oral Yeast Drug During Pregnancy

MedicalResearch.com Interview with:

Anick Bérard PhD FISPE Research chair FRQS on Medications and Pregnancy Director, Réseau Québécois de recherche sur le médicament (RQRM) Professor, Research Chair on Medications, Pregnancy and Lactation Faculty of Pharmacy, University of Montrealand Director, Research Unit on Medications and Pregnancy Research Center CHU Ste-Justine

Dr. Bérard

Anick Bérard PhD FISPE
Research chair FRQS on Medications and Pregnancy
Director, Réseau Québécois de recherche sur le médicament
Professor, Research Chair on Medications, Pregnancy and Lactation
Faculty of Pharmacy, University of Montrealand
Director, Research Unit on Medications and Pregnancy
Research Center
CHU Ste-Justin

 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Yeast infections are common during pregnancy (10%). Although topical treatments are first-line therapies, yeast infections during gestation are often more severe and are resistant to topical options. Hence, low dose oral fluconazole is often the treatment of choice for pregnant women (1 dose for 1 day).

Human and animal studies have shown that high dose of fluconazole is teratogenic.Few studies are available for the risk associated with low dose of fluconazole (the most used during pregnancy). Also, no one has studied the combined effect of low- and high-dose fluconazole use during pregnancy on overall adverse pregnancy outcomes (spontaneous abortions, stillbirths and major malformations). 

MedicalResearch.com: What should readers take away from your report?

Response: Regardless of dosage, oral fluconazole use is associated with the risk of spontaneous abortions. However, only high dose of fluconazole use during pregnancy is associated with cardiac defect – low dose is not associated with the risk of malformations. Oral fluconazole (low- or high-dose) is not associated with the risk of stillbirth. This is reassuring given that low-dose is the most frequently used.yeast infections should be treated during pregnancy.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Our study is consistent with what is already known. However, studies with even larger sample sizes would be needed to take into account potential residual confounding.   

Citation:

Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case–control studies

Anick BérardOdile SheehyJin-Ping ZhaoJessica GorguiSasha BernatskyCristiano Soares de Moura and Michal Abrahamowicz

 

Feb 19, 2019 @ 12:34 pm

 

 

 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

No Comments

Post A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.